Cridanimod – Neovir solution for intramuscular injection. 250 mg /2 ml ampoules 2 ml 5 pcs



Latin name


Release form

The solution for i / m administration is transparent, greenish-yellow.


2 ml – ampoules of dark glass (5) – blister strip packaging (1) – packs of cardboard.


As an immunostimulating agent in combination therapy: prevention and treatment of influenza and other acute respiratory diseases (including against the background of immunodeficiency states)

infections caused by Herpes simplex type 1 and 2 virus and Varicella zoster virus (in including in individuals with immune system disorders)

cytomegalovirus infection in individuals with

immunodeficiency radiation immunodeficiency

HIV treatment

encephalitis and encephalomyelitis viral etiology

acute and chronic hepatitis B and C srdlp retrites, epididymitis, prostatitis, cervicitis and salpingitis of chlamydial etiology

venereal lymphogranuloma

oncological diseases

multiple sclerosis

candidiasis of the skin and mucous membranes.


severe renal failure (CC less than 30 ml / min)

autoimmune diseases


lactation (breastfeeding)


hypersensitivity to the components of the drug.

Use with caution in elderly patients.

Use during pregnancy and lactation

The drug is contraindicated in pregnancy and lactation (breastfeeding).


1 ml

oxo dihydroacridinyl acetate 125 mg

Excipients: sodium citrate 2.5 mg, citric acid monohydrate 0.5-1.5 mg (up to pH 7.5-8.3), water d / and up to 1 ml.

Dosage and administration

Injection solution is administered in oil, a single dose is 250 mg (1 amp.) or 4-6 mg / kg of body weight. If necessary, a single dose of Neovir can be increased to 500 mg.

The course of treatment, if not specifically indicated, consists of 5-7 i / m injections in single doses with an interval of 48 hours. The course dose depends on the clinical picture. The duration of the course is 8-12 days. With prolonged and preventive use, the interval between Neovir injections is 3-7 days.

In HIV infections, the injection is used as part of combination therapy. The course of treatment consists of 10 i / m injections of 250 mg with an interval between injections of 48 hours. After a course of therapy, a break of 2 months is taken. The number of repeated courses is not limited.

Side effects

General reactions: low-grade fever, allergic reactions.

Local reactions: local, rapidly passing pain at the injection site.

Drug Interaction

No incompatibilities or potentiation of the drug when interacting with other medicinal products have been reported during clinical trials and use of the drug.

There is no information on the physico-chemical incompatibility of Neovir with other medicines.


Overdose on Neovir is not provided.

Storage conditions

List B. The drug should be stored in a dry, dark place, out of reach of children at a temperature of 15 ° to 25 ° C.

A cloudy solution for injection to a milky white color indicates a violation of storage conditions and unsuitability for use.

The Expiration of

is 3 years.

Deystvuyuschee substances


Conditions of supply of pharmacies


Pharmsintez PAO, Russia